Treatment with MB-10 (25 μM) for 24 h significantly decreased phosphorylation of Akt and p70S6 kinase 1 (S6K1) in priBlCa-1 primary bladder cancer cells (Fig. 7A). Here, RPS6KB1 is linked to urinary bladder cancer.